Early diagnosis and treatment of hepatitis C is critical to ending the epidemic. With sofosbuvir and simeprevir, combined with evidenced-based behavioral health interventions such as needle exchange and peer support we can -- and will -- save lives.
Read Whole Story
WASHINGTON — WASHINGTON (AP) — An experimental hepatitis C drug from Johnson & Johnson appears to be slightly more effective at eliminating th...
Get top stories and blog posts emailed to me each day..